NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

當地藥品交付市場(2020-2030年):產品(半固體,液體,固體,經皮產品),區域預測,主要公司的分析,從COVID-19危機中復甦的情景

Topical Drug Delivery Market Report 2020-2030: Forecasts by Product (Semi-solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products), by Region, plus Analysis of Leading Companies, and COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 977643
出版日期 內容資訊 英文 652 Pages
商品交期: 最快1-2個工作天內
價格
當地藥品交付市場(2020-2030年):產品(半固體,液體,固體,經皮產品),區域預測,主要公司的分析,從COVID-19危機中復甦的情景 Topical Drug Delivery Market Report 2020-2030: Forecasts by Product (Semi-solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products), by Region, plus Analysis of Leading Companies, and COVID-19 Recovery Scenarios
出版日期: 2020年10月22日內容資訊: 英文 652 Pages
簡介

推動全球本地藥物輸送市場增長的因素包括皮膚和眼部疾病的高患病率,燒傷的高發生率以及糖尿病的患病率增加。然而,由於長期應用引起的局部藥物的副作用仍然是市場發展的主要障礙。

本報告審查了全球本地藥品交付市場,包括市場規模和對2030年的預測,份額,機會,增長和限制,主要供應商,產品和管理部門的產品組合的比較和發展。它提供信息,例如按路線,最終用戶和地區進行的市場分析,競爭情況以及主要公司的概況。

目錄

第1章報告概述

第2章當地藥品投放市場概述

第3章執行摘要

  • 通過皮膚和眼部疾病的高流行,燒傷的高流行以及糖尿病的高流行來促進市場增長
  • 由於市場成熟,行業公司之間的激烈競爭
  • 對在日本,中國和印度等新興經濟體中提供增長機會的期望

第4章市場定性分析

  • SWOT分析
  • PEST分析
  • 波特的五力分析
  • 市場趨勢
  • 市場動態
    • 生長因子
    • 壓制者和挑戰
    • 市場機會
  • COVID-19影響分析

第5章市場分析:按產品分類(2020-2030)

  • 全球市場(包括COVID之前和恢復的情況)
  • 半固體配方:佔據大部分市場份額
  • 液體製劑:通過藥物控製作用和高生物利用度促進
  • 固體配方:由於粒徑非常細,需要適當的鹼
  • 透皮吸收產品:由於獨家優勢和易於管理,需求增加

第6章市場分析:按管理路線劃分(2020-2030)

  • 全球市場(包括COVID之前和恢復的情況)
  • 皮膚藥物遞送:主導市場份額
  • 眼科用藥:隨著眼部疾病的發生率增加而增加使用
  • 直腸給藥:由於藥物吸收不足而未採用
  • 陰道給藥:由於陰道組織的高滲透性而被採用
  • 鼻腔給藥:由於所用藥物的高效性,需求增加

第7章市場分析:按最終用戶(2020-2030)

  • 全球市場(包括COVID-19之前的版本和恢復方案)
  • 家庭護理:佔據大部分市場份額
  • 醫院和診所部門:手術部位感染的發生率提高
  • 燒傷治療中心:通過增加燒傷發生率來促進
  • 其他設施

第8章主要國內市場預測(2020-2030年)

  • 全球市場的區域細分(包括COVID前和恢復情景)

第9章北美市場(2020-2030)

  • 市場預測
  • 產品市場預測
  • 按行政途徑劃分的市場預測
  • 最終用戶的市場預測
  • 國家市場預測
  • 美國
  • 加拿大

第10章歐洲市場(2020-2030)

  • 市場預測
  • 產品市場預測
  • 按行政途徑劃分的市場預測
  • 最終用戶的市場預測
  • 國家市場預測
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 其他

第11章亞太市場(2020-2030)

  • 市場預測
  • 產品市場預測
  • 按行政途徑劃分的市場預測
  • 最終用戶的市場預測
  • 國家市場預測
  • 日本
  • 中國
  • 印度
  • 澳大利亞
  • 其他

第12章拉丁美洲,中東和非洲市場(2020-2030)

  • 市場預測
  • 產品市場預測
  • 按行政途徑劃分的市場預測
  • 最終用戶的市場預測
  • 國家市場預測
  • 巴西
  • 墨西哥
  • 其他

第13章主要公司簡介

  • GlaxoSmithKline
    • 公司簡介
    • 產品組合
    • 銷售分析
    • 戰略/發展
  • Johnson & Johnson
  • Bausch Health Companies.
  • Merck & Co.
  • LEO Pharma A/S
  • Hisamitsu Pharmaceutical Co. Inc.
  • Novartis AG.
  • Glenmark Pharmaceuticals
  • Cipla Limited.
  • Mylan N.V.

第14章 結論及建議

第15章 用語集

目錄
Product Code: PHA0811

Title:
Topical Drug Delivery Market Report 2020-2030
Forecasts by Product (Semi-solid Formulations (Creams, Ointments, Lotions, Gels, Pastes)), (Liquid Formulations (Suspensions, Solutions)), Solid Formulations (Powders, Suppositories)), and (Transdermal Products (Transdermal Patches, Transdermal Semi-solids), and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) PLUS Analysis of Leading Topical Drug Delivery Companies AND COVID-19 Recovery Scenarios.

Side Effects of topical drugs due to prolonged application still remains a key restraint in the development of the market. How can drug delivery companies get around this problem? Find out today.

Owing to the COVID-19 pandemic, the supply chain and demand of topical drug delivery has been affected in 2020. But it is not just COVID-19 that affects the future of topical drug delivery. This unique senior report tells you what direction the market will take - and it tells you today.

Discover how to stay ahead

Our 600+ page report provides 600+ tables, charts, and graphs.

By reading this report you will discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market, regional and country specific level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Topical drug delivery Market. See how you can exploit these opportunities.

UNIQUE COVID-19 VARIATIONS- only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 affects the economy.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
  • You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Which Factors are Fueling Topical drug delivery Industry Growth?

  • High Prevalence of Skin Diseases
  • High Prevalence of Eye Diseases
  • High Incidence of Burn Injuries
  • Increasing Prevalence of Diabetes

Which Factors are Restraining Growth?

  • Preference for Alternative Modes of Drug Delivery
  • Technical Barriers Related to Skin Irritation & Permeability
  • Side Effects of Topical Drugs Due to Prolonged Application

How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2030, evaluates critical development information, trends, opportunities and business outlooks.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter's Analysis, product profiles and commercial developments.

Report Scope

Global Topical Drug Delivery Market 2020-2030 is segmented on the basis of Product, Route of Administration, End User and Geography.

Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Product:

  • Semi-Solid Formulations
    • Creams
    • Ointments
    • Lotions
    • Gels
    • Pastes
  • Liquid Formulations
    • Suspensions
    • Solutions
  • Solid Formulations
    • Powders
    • Suppositories
  • Transdermal Products
    • Transdermal Patches
    • Transdermal Semi-solids

Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Route of Administration:

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by End-User:

  • Home Care Settings
  • Hospitals and Clinics
  • Burn Centres
  • Other Facilities

Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • LAMEA
    • Brazil
    • Mexico
    • Rest of LAMEA

Our study discusses the selected leading companies that are the major players in the Topical drug delivery industry:

  • GlaxoSmithKline
  • Johnson & Johnson
  • Bausch Health Companies
  • Merck & Co.
  • LEO Pharma
  • Hisamitsu Pharmaceutical
  • Novartis AG
  • Glenmark Pharmaceuticals
  • Cipla
  • Mylan AV

How the Topical drug delivery Market report helps you

In summary, our 600+ page report provides you with the following knowledge:

  • What is the current size of the overall global topical drug delivery market? How much will this market be worth from 2020 to 2030?
  • What are the main drivers and restraints that will shape the overall topical drug delivery market over the next ten years?
  • What are the main segments within the overall topical drug delivery market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
  • What factors will affect that industry and market over the next ten years?
  • Which are the leading companies and what are their activities, results, developments, and prospects?
  • What are the main trends that will affect the world topical drug delivery market between 2020 and 2030?
  • What are the main strengths, weaknesses, opportunities, and threats for the market?
  • How will the global topical drug delivery market evolve over the forecasted period, 2020 to 2030?
  • Revenue forecasts to 2030 for 4 regional and 10 key national markets - the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, Australia, and India. The report also highlights growth potential in Latin America as well as Middle East & Africa.
  • Prospects for established firms and those seeking to enter the market- including company profiles for over 10 of the major companies involved in the Topical drug delivery market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Topical drug delivery Market and leading companies. You will find data, trends and predictions.

Buy our report today Topical Drug Delivery Market Report 2020-2030: Forecasts by Product (Semi-solid Formulations (Creams, Ointments, Lotions, Gels, Pastes)), (Liquid Formulations (Suspensions, Solutions)), Solid Formulations (Powders, Suppositories)), and (Transdermal Products (Transdermal Patches, Transdermal Semi-solids), and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) PLUS Analysis of Leading Topical Drug Delivery Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed - order our report now.

Side Effects of topical drugs due to prolonged application still remains a key restraint in the development of the market. How can drug delivery companies get around this problem? Find out today.

Owing to the COVID-19 pandemic, the supply chain and demand of topical drug delivery has been affected in 2020. But it is not just COVID-19 that affects the future of topical drug delivery. This unique senior report tells you what direction the market will take - and it tells you today.

Discover how to stay ahead

Our 600+ page report provides 600+ tables, charts, and graphs.

By reading this report you will discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market, regional and country specific level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Topical drug delivery Market. See how you can exploit these opportunities.

UNIQUE COVID-19 VARIATIONS- only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 affects the economy.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction
  • 1.2 Why Should You Read This Report
  • 1.3 What This Report Deliver?
  • 1.4 Key Questions Answered by This Analytical Report
  • 1.5 Who is this Report for?
  • 1.6 Research Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
    • 1.6.3 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 About Visiongain

2. Introduction To The Topical Drug Delivery Market

  • 2.1 What is Topical Drug Delivery?
  • 2.2 Global Topical Drug Delivery Market Segmentation

3. Executive Summary

  • 3.1 High Prevalence Of Skin & Eye Diseases, High Incidence Of Burn Injuries, And The Growing Prevalence Of Diabetes to Fuel Market Growth
  • 3.2 Stiff Competition Among Industry Players Owing to Highly Mature Market
  • 3.3 Emerging Economies like Japan, China, and India Are Expected to Offer Lucrative Growth Opportunities

4. Qualitative Analysis of the Topical Drug Delivery Market

  • 4.1 SWOT Analysis
  • 4.2 PEST Analysis
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Supplier
    • 4.3.2 High Bargaining Power of Buyer
    • 4.3.3 Low Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Market Trends
  • 4.5 Market Dynamics
    • 4.5.1 Driver
      • 4.5.1.1 High Prevalence of Skin Diseases
      • 4.5.1.2 High Prevalence of Eye Diseases
      • 4.5.1.3 High Incidence of Burn Injuries
      • 4.5.1.3 Increasing Prevalence of Diabetes
    • 4.5.2 Restraints & Challenges
      • 4.5.2.1 Preference for Alternative Modes of Drug Delivery
      • 4.5.2.2 Technical Barriers Related to Skin Irritation & Permeability
      • 4.5.2.3 Side Effects of Topical Drugs Due to Prolonged Application
      • 4.5.2.4 Product Recall
      • 4.5.2.5 Impact of COVID-19 Pandemic on Supply Chain
    • 4.5.3 Opportunity
      • 4.5.3.1 Delivery of Biologics Through the Transdermal Route
  • 4.6 COVID-19 Impact Analysis

5. Global Topical Drug Delivery Market, By Product, 2020-2030

  • 5.1 Global Topical Drug Delivery Market Forecast by Product, 2020-2030 (Pre COVID & Recovery Scenarios Included)
  • 5.2 Semi-Solid Formulations Accounted for the Majority of the Market Share
    • 5.2.1 Semi-Solid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.2.2 Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
    • 5.2.7 Creams Accounted for the Majority of the Market Share
      • 5.2.7.1 Cream Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.2.8 Ointment are commonly used to treat analgesic-related indications
      • 5.2.8.1 Ointment Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.2.9 Lotions segment is driven due to its ease of administration
      • 5.2.9.1 Lotions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.2.10 Gels to Witness Highest Growth Rate Through 2030 owing to faster release of drug
      • 5.2.10.1 Gels Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.2.11 Paste are commonly adopted to treat and prevent skin irritation
      • 5.2.11.1 Paste Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 5.3 Liquid Formulations are driven owing to controlled drug action and high bioavailability rate
    • 5.3.1 Liquid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.3.2 Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
    • 5.3.7 Solutions Accounted for the Majority of the Market Share
      • 5.3.7.1 Solutions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.3.8 Suspensions to Witness Highest Growth Rate Through 2030
      • 5.3.8.1 Suspensions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 5.4 Solid Formulation are made of very fine particle size and need a suitable base
    • 5.4.1 Solid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.4.2 Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
    • 5.4.7 Powders Accounted for the Majority of the Market Share
      • 5.4.7.1 Powder Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.4.8 Suppositories to Witness Highest Growth Rate Through 2030
      • 5.4.8.1 Suppositories Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 5.5 Transdermal Products are increasing in demand due to exclusive advantages and ease of administration
    • 5.5.1 Transdermal Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.5.2 Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
    • 5.5.7 Transdermal Patches Accounted for the Majority of the Market Share
      • 5.5.7.1 Transdermal Patches Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
    • 5.5.8 Transdermal Semi-solids to Witness Highest Growth Rate Through 2030
      • 5.5.8.1 Transdermal Semi-solids Topical Drug Delivery Market By Region: Market Forecast, 2020-2030

6. Global Topical Drug Delivery Market, By Route of Administration, 2020-2030

  • 6.1 Global Topical Drug Delivery Market Forecast, by Route of Administration, 2020-2030 (Pre COVID & Recovery Scenarios Included)
  • 6.2 Dermal Drug Delivery Accounted for the Majority of the Market Share
    • 6.2.1 Topical Dermal Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 6.3 Ophthalmic Drug Delivery is increasingly being used due to increase in incidence of eye diseases
    • 6.3.1 Topical Ophthalmic Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 6.4 Rectal Drug Delivery is not being commonly used due to poor drug absorption through this route
    • 6.4.1 Topical Rectal Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 6.5 Vaginal Drug Delivery is being used owing to the high permeability of vaginal tissues
    • 6.5.1 Topical Vaginal Drug Delivery Market By Region: Market Forecast, 2020-2030
  • 6.6 Nasal Drug Delivery demand is increasing due to high efficacy of drugs administered through this route
    • 6.6.1 Topical Nasal Drug Delivery Market By Region: Market Forecast, 2020-2030

7. Global Topical Drug Delivery Market, By End Users, 2020-2030

  • 7.1 Global Topical Drug Delivery Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
  • 7.2 Home Care Settings Accounted for the Majority of the Market Share
    • 7.2.1 Topical Drug Delivery Market for home care settings By Region: Market Forecast, 2020-2030
  • 7.3 Hospitals and Clinics segment is driven by the increase in incidence of surgical-site infections
    • 7.3.1 Topical Drug Delivery Market for hospitals and clinics By Region: Market Forecast, 2020-2030
  • 7.4 Burn Centers segment is driven by increase in incidence of burn injuries
    • 7.4.1 Topical Drug Delivery Market for burn centers By Region: Market Forecast, 2020-2030
  • 7.5 Other Facilities
    • 7.5.1 Topical Drug Delivery Market for Other Facilities By Region: Market Forecast, 2020-2030

8. Leading National Markets Forecast 2020-2030

  • 8.1. Geographical Breakdown of Global Topical Drug Delivery Market, 2020-2030 (Pre COVID & Recovery Scenarios Included)

9. North America Topical Drug Delivery Market, 2020-2030

  • 9.1. North America Topical Drug Delivery Market Forecast, 2020-2030
  • 9.2. North America Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 9.2.1 North America Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 9.2.2 North America Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 9.2.3 North America Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 9.2.4 North America Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
  • 9.3. North America Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
  • 9.4. North America Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
  • 9.5. North America Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
  • 9.6 US Accounted for the Majority of the Market Share
    • 9.6.1 Increase in prevalence of skin diseases
    • 9.6.2 High number of product launches and approvals
    • 9.6.3 Recovery Scenarios (V, U, W, L)
  • 9.7. Canada Topical Drug Delivery Market
    • 9.7.1 Availability of funding to develop innovative topical drugs
    • 9.7.2 Recovery Scenarios (V, U, W, L)

10. Europe Topical Drug Delivery Market, 2020-2030

  • 10.1. Europe Topical Drug Delivery Market Forecast, 2020-2030
  • 10.2. Europe Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 10.2.1 Europe Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 10.2.2 Europe Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 10.2.3 Europe Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 10.2.4 Europe Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
  • 10.3. Europe Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
  • 10.4. Europe Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
  • 10.5. Europe Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
  • 10.6. Germany Topical Drug Delivery Market, 2020-2030
    • 10.6.1 Key players focusing on the development of topical products
    • 10.6.2 Established Healthcare System
    • 10.6.3 Recovery Scenarios (V, U, W, L)
  • 10.7. France Topical Drug Delivery Market
    • 10.7.1 Renowned Medical Care with Innovation
    • 10.7.2 Development Of Topical Drugs By Local Players
    • 10.7.3 Recovery Scenarios (V, U, W, L)
  • 10.8. UK Topical Drug Delivery Market
    • 10.8.1 Increase in prevalence of chronic conditions & skin diseases
    • 10.8.2 145,000 people diagnosed with Parkinson's disease in the UK
    • 10.8.3 Recovery Scenarios (V, U, W, L)
  • 10.9. Italy Topical Drug Delivery Market
    • 10.9.1 Large Elderly Population
    • 10.9.2 144,000 people diagnosed and living with Parkinson's in Italy in 2016
    • 10.9.3 Recovery Scenarios (V, U, W, L)
  • 10.10. Spain Topical Drug Delivery Market
    • 10.10.1 High Prevalence of Skin Conditions Across the Spanish Region
    • 10.10.2 300,000 people diagnosed and living with Parkinson's in Spain in 2016
    • 10.10.3 Recovery Scenarios (V, U, W, L)
  • 10.11. Rest of Europe Topical Drug Delivery Market
    • 10.11.4 Recovery Scenarios (V, U, W, L)

11. Asia-Pacific Topical Drug Delivery Market, 2020-2030

  • 11.1. Asia-Pacific Topical Drug Delivery Market Forecast, 2020-2030
  • 11.2. Asia-Pacific Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 11.2.1 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 11.2.2 Asia-Pacific Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 11.2.3 Asia-Pacific Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 11.2.4 Asia-Pacific Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
  • 11.3. Asia-Pacific Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
  • 11.4. Asia-Pacific Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
  • 11.5. Asia-Pacific Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
  • 11.6. Recovery Scenarios (V, U, W, L)
  • 11.7 Japan Topical Drug Delivery Market
    • 11.7.1. Increased R&D activities for the development of topical formulation among the local players
    • 11.7.2. Ageing Population
    • 11.7.3 Recovery Scenarios (V, U, W, L)
  • 11.8 China Topical Drug Delivery Market
    • 11.8.1 Presence of the large patient population
    • 11.8.2 Increased focus of local and major players to develop topical drugs
    • 11.8.3 Recovery Scenarios (V, U, W, L)
  • 11.9 India Topical Drug Delivery Market
    • 11.9.1 Rise in demand of non-invasive modes of drug delivery
    • 11.9.2 Increased awareness regarding the benefits of using topical drugs
    • 11.9.3 Recovery Scenarios (V, U, W, L)
  • 11.10 Australia Topical Drug Delivery Market
    • 11.10.1 Recovery Scenarios (V, U, W, L)
  • 11.11 Rest of Asia-Pacific Topical Drug Delivery Market
    • 11.11.1 Recovery Scenarios (V, U, W, L)

12. Latin America, Middle East & Africa (LAMEA) Topical Drug Delivery Market, 2020-2030

  • 12.2. LAMEA Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 12.2.1 LAMEA Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 12.2.2 LAMEA Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 12.2.3 LAMEA Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
    • 12.2.4 LAMEA Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
  • 12.3. LAMEA Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
  • 12.4. LAMEA Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
  • 12.5. LAMEA Topical Drug Delivery Market by Country: Market Forecast, 2020-2030
  • 12.6. Recovery Scenarios (V, U, W, L)
  • 12.7 Brazil Topical Drug Delivery Market
    • 12.7.1 Recovery Scenarios (V, U, W, L)
  • 12.8 Mexico Topical Drug Delivery Market
    • 12.8.1 Recovery Scenarios (V, U, W, L)
  • 12.9 Rest of LAMEA Topical Drug Delivery Market
    • 12.9.1 Recovery Scenarios (V, U, W, L)

13. Leading Company in Topical Drug Delivery Market

  • 13.1. GlaxoSmithKline
    • 13.1.1 Company Overview
    • 13.1.2 Product Portfolio
    • 13.1.3 Sales Analysis
    • 13.1.4 Strategies & Development
  • 13.2. Johnson & Johnson
    • 13.2.1 Company Overview
    • 13.2.2 Product Portfolio
    • 13.2.3 Sales Analysis
    • 13.2.4 Strategies & Development
  • 13.3. Bausch Health Companies.
    • 13.3.1 Company Overview
    • 13.3.2 Product Portfolio
    • 13.3.3 Sales Analysis
    • 13.3.4 Strategies & Development
  • 13.4. Merck & Co.
    • 13.4.1 Company Overview
    • 13.4.2 Product Portfolio
    • 13.4.3 Sales Analysis
  • 13.5. LEO Pharma A/S
    • 13.5.1 Company Overview
    • 13.5.2 Product Portfolio
    • 13.5.3 Sales Analysis
    • 13.5.4 Strategies & Development
  • 13.6. Hisamitsu Pharmaceutical Co. Inc.
    • 13.6.1 Company Overview
    • 13.6.2 Product Portfolio
    • 13.6.3 Sales Analysis
    • 13.6.4 Strategies & Development
  • 13.7. Novartis AG.
    • 13.7.1 Company Overview
    • 13.7.2 Product Portfolio
    • 13.7.3 Sales Analysis
    • 13.7.4 Strategies & Development
  • 13.8. Glenmark Pharmaceuticals
    • 13.8.1 Company Overview
    • 13.8.2 Product Portfolio
    • 13.8.3 Sales Analysis
    • 13.8.4 Strategies & Development
  • 13.9. Cipla Limited.
    • 13.8.1 Company Overview
    • 13.9.2 Product Portfolio
    • 13.9.3 Sales Analysis
    • 13.9.4 Strategies & Development
  • 13.10. Mylan N.V.
    • 13.10.1 Company Overview
    • 13.10.2 Product Portfolio
    • 13.10.3 Sales Analysis
    • 13.10.4 Strategies & Development

14. Conclusion & Recommendation

15. Glossary

List of Tables

  • Table. 1 Global Topical Drug Delivery Market, 2019 & 2030, Executive Summary (US$mn) & CAGR (%)
  • Table. 2 Global Topical Drug Delivery Market Revenue By Product(USD Mn), V-Shaped Recovery, 2020-2030
  • Table. 3 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), V-Shaped Recovery, 2020-2030
  • Table. 4 Global Topical Drug Delivery Market Revenue By End user (USD Mn), V-Shaped Recovery, 2020-2030
  • Table. 5 Global Topical Drug Delivery Market Revenue By Region (USD Mn), V-Shaped Recovery, 2020-2030
  • Table. 6
  • Table. 7 Global Topical Drug Delivery Market Revenue By Product (USD Mn), U-Shaped Recovery, 2020-2030
  • Table. 8 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), U-Shaped Recovery, 2020-2030
  • Table. 9 Global Topical Drug Delivery Market Revenue By End user (USD Mn), U-Shaped Recovery, 2020-2030
  • Table. 10 Global Topical Drug Delivery Market Revenue By Region (USD Mn), U-Shaped Recovery, 2020-2030
  • Table. 11 Global Topical Drug Delivery Market Revenue By Product (USD Mn), L-Shaped Recovery, 2020-2030
  • Table. 12 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), L-Shaped Recovery, 2020-2030
  • Table. 13 Global Topical Drug Delivery Market Revenue By End user (USD Mn), L-Shaped Recovery, 2020-2030
  • Table. 14 Global Topical Drug Delivery Market Revenue By Region (USD Mn), L-Shaped Recovery, 2020-2030
  • Table. 15
  • Table. 16 Global Topical Drug Delivery Market Revenue By Product (USD Mn), W-Shaped Recovery, 2020-2030
  • Table. 17 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), W-Shaped Recovery, 2020-2030
  • Table. 18 Global Topical Drug Delivery Market Revenue By End user (USD Mn), W-Shaped Recovery, 2020-2030
  • Table. 19 Global Topical Drug Delivery Market Revenue By Region (USD Mn), W-Shaped Recovery, 2020-2030
  • Table. 20 Global Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 21 Global Semi-Solid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
  • Table. 22 Global Semi-Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 23 Global Cream Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 24 Global Ointment Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Source: Visiongain 2020
  • Table. 25 Global Lotions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 26 Global Gels Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 27 Global Paste Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 28 Global Liquid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
  • Table. 29
  • Table. 30 Global Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 31 Global Solutions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 32 Global Suspensions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Source: Visiongain 2020
  • Table. 33 Global Solid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
  • Table. 34 Global Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 35 Global Powder Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 36 Global Suppositories Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 37 Global Transdermal Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
  • Table. 38 Global Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 39 Global Transdermal Patches Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 40 Global Transdermal Semi-solids Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 41 Global Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 42 Global Topical Dermal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 43 Global Topical Ophthalmic Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 44 Global Topical Rectal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 45 Global Topical Vaginal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 46 Global Topical Nasal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 47 Global Topical Drug Delivery Market Revenue, By End User (USD Mn), 2020-2030
  • Table. 48 Global Topical Rectal Drug Delivery Market Revenue for home care settings, By Region (USD Mn), 2020-2030
  • Table. 49 Global Topical Drug Delivery Market Revenue for hospitals and clinics, By Region (USD Mn), 2020-2030
  • Table. 50 Global Topical Rectal Drug Delivery Market Revenue for burn centers, By Region (USD Mn), 2020-2030
  • Table. 51 Global Topical Drug Delivery Market Revenue for Other Facilities, By Region (USD Mn), 2020-2030
  • Table. 52 Global Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
  • Table. 53 North America Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 54 North America Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 55 North America Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 56 North America Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 57 North America Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 58 North America Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 59 North America Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 60 North America Topical Drug Delivery Market Revenue, By Country (USD Mn), 2020-2030
  • Table. 61 US Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 62 US Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 63 US Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 64 US Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 65 US Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 66 US Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 67 US Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 68 Canada Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 69 Canada Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 70 Canada Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 71 Canada Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 72 Canada Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 73 Canada Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 74 Canada Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 75 Europe Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 76 Europe Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 77 Europe Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 78 Europe Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 79 Europe Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 80 Europe Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 81 Europe Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 82 Europe Topical Drug Delivery Market Revenue, By Country (USD Mn), 2020-2030
  • Table. 83 Germany Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 84 Germany Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 85 Germany Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 86 Germany Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 87 Germany Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 88 Germany Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 89 Germany Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 90 France Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 91 France Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 92 France Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 93 France Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 94 France Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 95 France Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 96 France Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 97 UK Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 98 UK Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 99 UK Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 100 UK Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 101 UK Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 102 UK Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 103 UK Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 104 Italy Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 105 Italy Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 106 Italy Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 107 Italy Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 108 Italy Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 109 Italy Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 110 Italy Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 111 Spain Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 112 Spain Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 113 Spain Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 114 Spain Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 115 Spain Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 116 Spain Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 117 Spain Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 118 Rest of Europe Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
  • Table. 119 Rest of Europe Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 120 Rest of Europe Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 121 Rest of Europe Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 122 Rest of Europe Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 123 Rest of Europe Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
  • Table. 124 Rest of Europe Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
  • Table. 125 Asia-Pacific Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 126 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 127 Asia-Pacific Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 128 Asia-Pacific Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 129 Asia-Pacific Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 130 Asia-Pacific Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 131 Asia-Pacific Topical Drug Delivery Market Revenue By End-User (USD Mn), 2020-2030
  • Table. 132 Asia-Pacific Topical Drug Delivery Market Revenue By Country (USD Mn), 2020-2030
  • Table. 133 Japan Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 134 Japan Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 135 Japan Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 136 Japan Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 137 Japan Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 138 Japan Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 139 Japan Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 140 China Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 141 China Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 142 China Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 143 China Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 144 China Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 145 China Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 146 China Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 147 India Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 148 India Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 149 India Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 150 India Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 151 India Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 152 India Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 153 India Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 154 Australia Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 155 Australia Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 156 Australia Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 157 Australia Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 158 Australia Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 159 Australia Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 160 Australia Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 161 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 162 Rest of APAC Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 163 Rest of APAC Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 164 Rest of APAC Soild Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 165 Rest of APAC Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 166 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 167 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 168 LAMEA Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 169 LAMEA Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 170 LAMEA Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 171 LAMEA Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 172 LAMEA Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 173 LAMEA Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 174 LAMEA Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-230
  • Table. 175 LAMEA Topical Drug Delivery Market Revenue By Country (USD Mn), 2020-2030
  • Table. 176 Brazil Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 177 Brazil Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 178 Brazil Liquid Formuations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 179 Brazil Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 180 Brazil Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 181 Brazil Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 182 Brazil Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 183 Mexico Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 184 Mexico Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 185 Mexico Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 186 Mexico Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 187 Mexico Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 188 Mexico Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 189 Mexico Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 190 Rest of LAMEA Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 191 Rest of LAMEA Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 192 Rest of LAMEA Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 193 Rest of LAMEA Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 194 Rest of LAMEA Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
  • Table. 195 Rest of LAMEA Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
  • Table. 196 Rest of LAMEA Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
  • Table. 197 GlaxoSmithKline Company Overview
  • Table. 198 GlaxoSmithKline Product Portfolio
  • Table. 199 Product Portfolio
  • Table. 200 Johnson & Johnson Product Portfolio
  • Table. 201 Johnson & Johnson Product Portfolio
  • Table. 202 Johnson & Johnson Strategies aand Development
  • Table. 203 Baush Health Company Overview
  • Table. 204 Baush Health Company Product Portfolio
  • Table. 205 Baush Health Company Strategies & Development
  • Table. 206 Merck & Co. Overview
  • Merck & Co. Product Portfolio
  • Table. 207 Merxk & Co. Product Portfolio
  • Table. 208 Leo Pharma A/S Overview
  • Table. 209 Leo Pharma A/S Product Portfolio
  • Table. 210 Leo Pharma A/S Strategies & Development
  • Table. 211 Hisamitsu Pharmaceutical Co. Inc. Overview
  • Table. 212 Hisamitsu Pharmaceutical Co. Inc. Product Portfolio
  • Table. 213 Hisamitsu Pharmaceutical Co. Inc. Strategies & Development
  • Table. 214 Novartis AG. Overview
  • Table. 215 Novartis AG. Product Portfolio
  • Table. 216 Novartis AG. Strategies & Development
  • Table. 217 Glenmark Pharmaceuticals Overview
  • Table. 218 Glenmark Pharmaceuticals Product Portfolio
  • Table. 219 Glenmark Pharmaceuticals Strategies & Development
  • Table. 220 Cipla Limited Overview
  • Table. 221 Cipla Limited Product Portfolio
  • Table. 222 Cipla Limited Strategies & development
  • Table. 223 Mylan N.V. Overview
  • Table. 224 Mylan N.V. Product Portfolio
  • Table. 225 Mylan N.V. Strategies & Development

List of Figures

  • FIG. 1 Global Topical Drug Delivery Market (USD Million), 2019-2030
  • FIG. 2 Global Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 3 Global Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 4 Global Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 5 Global Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 6 Low Bargaining Power of Supplier
  • FIG. 7 High Bargaining Power of Buyer
  • FIG. 8 Low Threat of New Entrants
  • FIG. 9 Low Threat of Substitutes
  • FIG. 10 High Intensity Of Competitive Rivalry
  • FIG. 11 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 12 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 13 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 14 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 15 Global Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 16 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 17 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 18 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 19 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 20 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 21 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 22 Global Cream Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 23 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 24 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 25 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 26 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 27 Global Ointment Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 28 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 29 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 30 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 31 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 32 Global Lotion Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 33 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 34 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 35 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 36 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 37 Global Gels Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 38 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 39 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 40 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 41 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 42 Global Paste Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 43 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 44 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 45 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 46 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 47 Global Liquid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 48 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 49 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 50 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 51 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 52 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 53 Global Solutions Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 54 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 55 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 56 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 57 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 58 Global Suspensions Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 59 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 60 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 61 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 62 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 63 Global Solid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 64 Global Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 65 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 66 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 67 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 68 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 69 Global Powder Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 70 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 71 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 72 COVID-19 Impact on Powder Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 73 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 74 Global SuppositoriesTopical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 75 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 76 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 77 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 78 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 79 Global Transdermal Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 80 Global Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 81 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 82 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 83 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 84 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 85 Global Transdermal Patches Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 86 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 87 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 88 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 89 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 90 Global Transdermal Semi-solids Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 91 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 92 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 93 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 94 COVID-19 Impact on Transdermal Semi-Solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 95 Global Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 96 Global Topical Dermal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 97 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 98 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 99 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 100 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 101 Global Topical Ophthalmic Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 102 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 103 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 104 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 105 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 106 Global Topical Rectal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 107 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 108 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 109 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 110 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 111 Global Topical Vaginal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 112 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 113 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 114 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 115 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 116 Global Topical Nasal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 117 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 118 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 119 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 120 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 121 Global Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
  • FIG. 122 Global Topical Drug Delivery Market for home care settings Value Share (%), by Region, (2019 & 2030)
  • FIG. 123 COVID-19 Impact on Topical Drug Delivery Market for Home care settings (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 124 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 125 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 126 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 127 Global Topical Drug Delivery Market for hospitals and clinics Value Share (%), by Region, (2019 & 2030)
  • FIG. 128 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 129 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 130 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 131 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 132 Global Topical Drug Delivery Market Value Share (%) for burn centers, by Region, (2019 & 2030)
  • FIG. 133 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 134 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 135 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 136 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD
  • FIG. 137 Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 138 Global Topical Drug Delivery Market Value Share (%) for Other Facilities, by Region, (2019 & 2030)
  • FIG. 139 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 140 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 141 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 142 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 143 Global Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
  • FIG. 144 North America Topical Drug Delivery Market (USD Million), 2019-2030
  • FIG. 145 North America Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 146 North America Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 147 North America Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 148 North America Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 149 North America Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 150 North America Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 151 North America Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
  • FIG. 152 North America Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
  • FIG. 153 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 154 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 155 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 156 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 157 US Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 158 US Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 159 US Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 160 US Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 161 US Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 162 US Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 163 US Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 164 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 165 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 166 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 167 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 168 Canada Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 169 Canada Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 170 Canada Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 171 Canada Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 172 Canada Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 173 Canada Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 174 Canada Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 175 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 176 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 177 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 178 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 179 Europe Topical Drug Delivery Market (USD Million), 2019-2030
  • FIG. 180 Europe Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 181 Europe Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 182 Europe Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 183 Europe Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 184 Europe Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 185 Europe Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 186 Europe Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 187 Europe Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
  • FIG. 188 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 189 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 190 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 191 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 192 Germany Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 193 Germany Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 194 Germany Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 195 Germany Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 196 Germany Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 197 Germany Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 198 Germany Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 199 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 200 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 201 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 202 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 203 France Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 204 France Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 205 France Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 206 France Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 207 France Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 208 France Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 209 France Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 210 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 211 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 212 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 213 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 214 UK Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 215 UK Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 216 UK Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 217 UK Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 218 UK Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 219 UK Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 220 UK Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
  • FIG. 221 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 222 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 223 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 224 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 225 Italy Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 226 Italy Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 227 Italy Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 228 Italy Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 229 Italy Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 230 Italy Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 231 Italy Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 232 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 233 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 234 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 235 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 236 Spain Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 237 Spain Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 238 Spain Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 239 Spain Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 240 Spain Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 241 Spain Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 242 Spain Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 243 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 244 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 245 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 246 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 247 Rest of Europe Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 248 Rest of Europe Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 249 Rest of Europe Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 250 Rest of Europe Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 251 Rest of Europe Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 252 Rest of Europe Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 253 Rest of Europe Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
  • FIG. 254 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 255 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 256 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 257 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 258 Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030
  • FIG. 259 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 260 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 261 Asia-Pacific Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 262 Asia-Pacific Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 263 Asia-Pacific Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 264 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 265 Asia-Pacific Topical Drug Delivery Market Value Share (%), by End-user, (2019 & 2030)
  • FIG. 266 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
  • FIG. 267 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 268 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 269 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 270 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 271 Japan Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 272 Japan Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 273 Japan Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 274 Japan Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 275 Japan Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 276 Japan Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 277 Japan Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 278 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 279 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 280 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 281 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 282 China Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 283 China Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 284 China Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 285 China Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 286 China Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 287 China Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 288 China Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 289 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 290 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 291 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 292 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 293 India Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 294 India Semi-Solids Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 295 India Liquid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 296 India Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 297 India Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 298 India Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 299 India Topical Drug Delivery Market Value Share (%), by End-user, (2019 & 2030)
  • FIG. 300 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 301 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 302 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 303 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 304 Australia Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 305 Australia Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 306 Australia Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 307 Australia Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 308 Australia Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 309 Australia Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 310 Australia Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 311 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 312 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 313 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 314 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 315 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 316 Rest of APAC Semi-Solids Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 317 Rest of APAC Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 318 Rest of APAC Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 319 Rest of APAC Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 320 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 321 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 322 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 323 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 324 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 325 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 326 LAMEA Topical Drug Delivery Market (USD Million), 2019-2030
  • FIG. 327 LAMEA Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 328 LAMEA Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 329 LAMEA Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 330 LAMEA Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 331 LAMEA Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 332 LAMEA Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 333 LAMEA Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 334 LAMEA Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
  • FIG. 335 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 336 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 337 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 338 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 339 Brazil Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 340 Brazil Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 341 Brazil Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 342 Brazil Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 343 Brazil Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 344 Brazil Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 345 Brazil Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 346 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 347 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 348 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 349 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 350 Mexico Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 351 Mexico Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 352 Mexico Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 353 Mexico Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 354 Mexico Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 355 Mexico Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 356 Mexico Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 357 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 358 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 359 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 360 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 361 Rest of LAMEA Topical Drug Delivery Market Value Share (%), Product, (2019 & 2030)
  • FIG. 362 Rest of LAMEA Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 363 Rest of LAMEA Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 364 Rest of LAMEA Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 365 Rest of LAMEA Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
  • FIG. 366 Rest of LAMEA Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
  • FIG. 367 Rest of LAMEA Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
  • FIG. 368 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
  • FIG. 369 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
  • FIG. 370 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
  • FIG. 371 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
  • FIG. 372 GlaxoSmithKline Sales (USD million)
  • FIG. 373 Glaxosmithkline Sales (USD million), By Business Segment
  • FIG. 374 Glaxosmithkline Sales (USD million), By Business
  • FIG. 375 Glaxosmithkline Sales (USD million), By Geography
  • FIG. 376 GlaxoSmithKline Sales (USD million) by Geography
  • FIG. 377 Johnson & Johnson Sales (USD million)
  • FIG. 378 Johnson & Johnson Sales (USD million), By Business Segment
  • FIG. 379 Johnson & Johnson Sales (USD million), By Geography
  • FIG. 380 Bausch Health Companies Sales (USD million) 2015-2019
  • FIG. 381 Bausch Health Companies Sales (USD million) 2019, By Business Segment
  • FIG. 382 Bausch Health Companies Sales (USD million) 2019, By Geography
  • FIG. 383 Merck & Co. Sales (USD million) 2015-2019
  • FIG. 384 Merck & Co. Sales (USD million) 2019, By Business Segment
  • FIG. 385 Merck & Co. Sales (USD million) 2019, By Geography
  • FIG. 386 LEO Pharma A/S Sales (USD million) 2015-2019
  • FIG. 387 LEO Pharma A/S Sales (USD million) 2019, By Business Segment
  • FIG. 388 LEO Pharma A/S Sales (USD million) 2019, By Geography
  • FIG. 389 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2015-2019
  • FIG. 390 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Business Segment
  • FIG. 391 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Business Segment
  • FIG. 392 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Geography
  • FIG. 393 Novartis AG. Sales (USD million) 2015-2019
  • FIG. 394 Novartis AG Sales (USD million) 2019, By Business Segment
  • FIG. 395 Novartis AG Sales (USD million) 2019, By Geography
  • FIG. 396 Glenmark Pharmaceuticals Sales (USD million) 2015-2019
  • FIG. 397 Glenmark Pharmaceuticals Sales (USD million) 2019, By Geography
  • FIG. 398 Cipla Limited Sales (USD million) 2015-2019
  • FIG. 399 Cipla Limited Sales (USD million) 2019, By Business Segment
  • FIG. 400 Cipla Limited Sales (USD million) 2019, By Geography
  • FIG. 401 Mylan N.V. Sales (USD million) 2015-2019
  • FIG. 402 Mylan N.V. Sales (USD million) 2019, By Business Segment
  • FIG. 403 Mylan N.V. Sales (USD million) 2019, By Geography

Companies Profiled in the Report:

  • Bausch Health Companies
  • Cipla Ltd.
  • Glaxosmithkline
  • Glenmark Pharmaceuticals
  • Hisamitsu Pharmaceutical Co. Inc.
  • Johnson & Johnson
  • LEO Pharma A/S
  • Merck & Co.
  • Mylan N.V.
  • Novartis AG

List of Other Companies:

  • 3M
  • 4P Therapeutics
  • AbbVie
  • Abbvie Inc.
  • Acrux Limited
  • Actuated Medical, Inc.
  • Adhex Pharma
  • Allergan plc
  • Almirall S.A.
  • Amgen
  • Antares Pharma, Inc.
  • Appco Pharmaceutical Corp
  • Arecor
  • Astellas
  • Atral
  • AVIZ Laboratories
  • AVRO Life Science
  • Basic Pharma
  • Bayer Ag
  • Bidu Biotech
  • Biofarmitalia s.r.l
  • Biozoc INC
  • Blaze Remedies
  • Bliss Gvs Pharma Ltd
  • Bluewaterresearch
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cambrex Corporation
  • Camurus
  • Carbogen Amcis SAS
  • Centurion Laboratories Private Limited
  • Concert Pharmaceuticals
  • Connote Healthcare
  • Corium International, Inc.
  • Cospex Pharmaceuticals Private Limited
  • Crescita Therapeutics Inc
  • Crescita TherapeuticsiNC
  • Delpharm Group
  • Dolvis Bio Pharma Private Limited
  • DPT Laboratories, Ltd.
  • Durect Corporation
  • Easton Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Endo Pharmaceuticals Inc.
  • Enfucell
  • Estrellas Life Sciences Private Limited
  • eurofins
  • Famar S.A.
  • Famar S.A.
  • Farbe Firma
  • Flagship biotech
  • Galderma
  • Galderma Holding SA
  • Glint Cosmetics Private Limited
  • Gracure Pharmaceuticals Ltd.
  • Grunenthal's Tecnandina S.A.
  • Guru Baba Pharmax Private Limited
  • Healthkind Labs Pvt. Ltd.
  • Integrated Laboratories Private Limited
  • Isis Biopolymer
  • Janssen Global Services
  • JGL
  • Jubilant HollisterStier
  • Laboratories Chemineau
  • Laboratories Gilbert
  • Lancer Therapeutics
  • Lavipharm
  • Lead Chemicals Co., Inc.
  • Lecifarma
  • Legacy Pharmaceuticals Switzerland
  • Lexine Technochem Private Limited
  • Lohmann Therapie-Systeme AG
  • Lohmann Therapie-Systeme AG
  • Lupin Ltd
  • M/S Slash Life Vision
  • Mayne Pharma
  • Medherant
  • Medix Biocare
  • Medpharm
  • MEDRx Co. Ltd.
  • Micropoint Technologies
  • Mission Pharmacal
  • Neptune Life Sciences Private Limited
  • Nestle
  • Nitto Denko Corp.
  • Nitto Denko Corporation
  • Nitto Denko Corporation
  • Novosis AG
  • One Pharma S.A.
  • Panacea Biotec
  • Pfizer, Inc.
  • Pharmatek Laboratories
  • Pharmatis
  • Pocono Coated Products LLC
  • Pocono Coated Products LLC
  • Polpharma
  • Priyans Drugs
  • Prometheon Pharma
  • Prosollus Pharmaceuticals
  • Puneet Laboratories Private Limited
  • Purdue Pharma L.P.
  • Rafarm S.A
  • Raphas Co. Ltd.
  • Recipharm
  • Rezicure Pharmaceuticals
  • S.C. Rompharm Company SRL
  • Salvus Pharma
  • Samyang Biopharmaceuticals Corporation
  • Saneca Pharmaceuticals
  • Saphnix Life Science
  • Sheffield Pharmaceuticals, Inc.
  • Sienna Biopharmaceuticals
  • Sirnaomics, Inc
  • Skinvisible Pharmaceuticals, Inc.
  • Skinvisible Pharmaceuticals, Inc.
  • Skylla Pharmaceuticals
  • Sofarimex
  • Softigel
  • SOLVAY S.A
  • Specpharm
  • Stellar- Bio Labs
  • Stiefel Laboratories, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Tapemark
  • Teikoku Pharma
  • Teva Pharmaceuticals
  • The Madras Pharmaceuticals
  • TheraSolve NV.
  • Topical Pharmaceuticals Inc.
  • Transdermal Technologies, Inc.
  • Trumac Healthcare
  • UPM Pharmaceuticals
  • Valeant Pharmaceuticals International, Inc.
  • Vasa Cosmetics Private Limited
  • WellSpring Pharmaceutical
  • Zosano
  • Zynerba Pharmaceuticals

List of Organizations Mentioned in the Report:

  • AiM at Melanoma Foundation
  • American Academy of Dermatology (AAD)
  • American Burn Association
  • Australian Institute of Health & Welfare
  • BrightFocus Foundation
  • Bureau of Labor Statistics
  • Canadian Dermatology Association
  • Cancer Research UK
  • Emory University School of Medicine
  • Foreign Direct Investment (FDA)
  • Georgia Institute of Technology
  • Global Cancer observatory
  • Global Psoriasis Atlas
  • Guttmacher Institute
  • India Brand Equity Foundation (IBEF)
  • International Diabetes Federation (IDF)
  • Journal de Mycologie Medicine
  • National Health Service
  • National Institute of allergy and Infectious diseases
  • Neurological Health Charities Canada (NHCC)
  • NHSN Surgical Site Infection Surveillance
  • NIBIB Quantum Grant
  • Oculus Innovative Science
  • U.S. Department of Agriculture (USDA)
  • UN Department of Economic and Social Affairs
  • World Cancer Research Fund International
  • World health Organization (WHO)